Peptides for muscle gain: what the TikTok fitness crowd gets wrong

What did @jacoboestreichercoaching actually say?

The creator's core argument is that MK-677 is overhyped among newer lifters and will make you "really hungry" without delivering meaningful muscle growth. He frames the expected outcome bluntly: you eat too much, you get fat, then you spend a long time in a caloric deficit that undermines muscle retention. He also warns that MK-677 could "wind up giving yourself diabetes." No dosing advice, no endorsement, just a fairly aggressive warning against taking it at all.

This is not a nuanced clinical breakdown. It's a gym-bro intervention aimed at beginners who've probably seen MK-677 marketed as a shortcut to size. The tone is combative, the language is coarse, and the actual mechanism explanation is thin. But the underlying instinct, that MK-677 is not a muscle-building silver bullet, is worth examining against what the research actually shows.

Does the science back this up?

Mostly, yes, though the picture is more complicated than the creator lets on. MK-677 is a ghrelin mimetic and oral growth hormone secretagogue. It does raise GH and IGF-1 levels, but that does not translate cleanly into lean mass in healthy young people who are already eating enough.

A 2008 randomized controlled trial by Svensson et al. in the Journal of Clinical Endocrinology and Metabolism found that while MK-677 significantly increased GH and IGF-1 in obese men, it also increased appetite substantially and led to modest fat-free mass gains alongside fat gain. The net body composition change was not impressive. A 1998 study by Chapman et al. in the same journal showed similar appetite-stimulating effects in elderly subjects, a population where the risk-benefit calculation looks different. In healthy, well-fed younger adults training regularly, the marginal muscle-building benefit from elevated GH secretion appears to be small, and the appetite amplification is real. The creator's instinct here is directionally correct.

What did they get wrong or right?

He got the appetite effect right. He got the fat gain risk right for undisciplined users. He got the diabetes concern partially right but overstated it. Where he fell short is in painting MK-677 as universally useless.

On the diabetes claim: MK-677 is documented to reduce insulin sensitivity. A study by Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) noted increased fasting glucose and insulin resistance in subjects using it. That is a real metabolic concern, particularly for people with existing insulin resistance or poor diet quality. But "you could wind up giving yourself diabetes" is an overstatement for an otherwise healthy person in the short term. It is not the same as saying the risk is negligible either.

What he missed entirely is that MK-677 does have studied applications in populations with GH deficiency, muscle wasting conditions, and age-related sarcopenia. Writing it off as something that "is not going to do much" ignores legitimate clinical contexts. For the average beginner lifter, though? He's not wrong that it's a poor choice.

What should you actually know?

MK-677 is not approved by the FDA as a drug for any indication. It is sometimes used off-label and is sold as a research chemical. Any use outside of a supervised medical context carries real risk, and the risks are not just theoretical.

The appetite stimulation from MK-677 is consistent and well-documented. For someone without strong dietary discipline, that effect alone can easily push caloric intake far beyond what muscle protein synthesis can absorb, leading to fat accumulation exactly as the creator describes. The insulin sensitivity reduction compounds that problem. Studies like those from Copinschi et al. (1997, Sleep) also document sleep disturbances and increased cortisol in some users, neither of which helps body composition.

If you are a newer lifter, the variables you actually control, training consistency, protein intake, sleep, and progressive overload, will produce far better results than any secretagogue. The creator's bottom line here is sound even if the clinical detail is thin. MK-677 is not a beginner tool, and the risk-reward ratio for healthy young people without GH deficiency is genuinely poor.